insulin detemir
NN304-1762
Approved small_molecule completed
Quick answer
insulin detemir for Diabetes is a Approved program (small_molecule) at Novo Nordisk A/S with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Diabetes
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed